On Feb. 1, 2014, the World Trade Center (WTC) Health Program announced it will consider certain blood or bone marrow disorders as WTC-related covered health conditions. According to the WTC Health Program, recent scientific advances characterize these “pre-leukemic” myeloid neoplasms as slow-growing blood cancers, with many sources now considering them to be malignant. As a result, the WTC Health Program has added them as WTC-related health conditions, making them available for WTC Health Program medical treatment services for eligible members.
These conditions include:
Acute myeloid leukemia
Myelodysplastic Syndromes (MDSs)
Myeloproliferative neoplasms (MPNs)
Myelodysplastic/myeloproliferative neoplasms (MDS/MPN)
Myeloid malignancies associated with eosinophilia and abnormalities of growth factor receptors derived from platelets or fibroblasts
As in past additions by the WTC Health Program, we anticipate the 9/11 Victim Compensation Fund (VCF) will consider these modifications to the list of presumptively covered conditions.
Learn more about the 9/11 Victim Compensation Fund
If you or a loved one suffered from a physical injury, illness or death potentially connected to 9/11 toxic exposure or debris removal and would like to consult with a Motley Rice 9/11 lawyer, call 1.800.768.4026 ext. 9649.